#adenom

• Acromegalic — Suffering from acromegaly; characterized by the excessive and disproportionate development of the body's extremities (hands, feet, facial bones, nose, jaw) due to the pathological hypersecretion of growth hormone (somatotropin) after the closure of epiphyseal plates. As a noun, it designates a male individual clinically diagnosed with this chronic neuroendocrine condition, most commonly triggered by a pituitary adenoma.
• Acromegalic — A synonymous variant of the adjective acromegal; relating to acromegaly, manifesting its symptoms, or affected by the hypersecretion of somatotropin. As a noun, the term defines a male individual presenting the clinical picture of the disease, marked by hypertrophy of the facial bones, hands, and feet secondary to a pituitary adenoma.
• Acromegalic woman — The feminine form of the word 'acromegalic'; it defines a female individual or a physical manifestation affected by this neuroendocrine dysfunction. The symptomatology in women comprises, alongside facial and skeletal changes, frequent associations with secondary hypertension and voice deepening.
• Acromegaly — A chronic neuroendocrine disease caused by a pathological hypersecretion of growth hormone (somatotropin) and insulin-like growth factor (IGF-1) in adulthood, after the closure of epiphyseal growth plates. The condition is characterized by the exaggerated enlargement of skeletal extremities (hands, feet), hypertrophy of facial bones (prognatism, prominent brow ridges), soft tissue thickening, macroglossia, and secondary severe cardiac or metabolic dysfunctions.
• Adenocyst — A cystic formation developing from a glandular structure or a benign/malignant tumor with a cystic appearance and epithelial-secretory origin. This structural entity is characterized by a central cavity filled with fluid or mucus, lined by a cellular wall derived from the epithelial cells of the affected gland, often requiring diagnostic differential imaging or histopathological analysis.
• Adenochondroma — A benign tumor formation with a mixed histological structure, characterized by the simultaneous proliferation of epithelial glandular tissue and cartilaginous tissue. This structural benign neoplasm occurs most frequently within the salivary glands (particularly in pleomorphic adenomas) or the mammary gland, presenting a slow evolution and sharp demarcation from surrounding tissues.
• Adenofibroma — A form of benign tumor with a mixed structure, characterized by the simultaneous and balanced proliferation of glandular epithelial elements and fibrous connective supporting tissue. This nodular lesion structurally develops most frequently within the mammary gland (where it is also known as fibroadenoma) or the ovaries, presenting upon palpation as a firm, mobile, and well-circumscribed mass.
• Adenoma — A form of benign tumor that structurally develops from the epithelial cells of a gland or from tissues exhibiting glandular structures. Although it is non-cancerous and does not metastasize, an adenoma can cause significant clinical problems by compressing neighboring organs or through the excessive and uncontrolled secretion of hormones, as occurs in endocrine glands.
• Adenomalacia — A rare pathological condition characterized by the abnormal softening, loss of firm consistency, or structural degeneration of a gland or a lymph node. This clinical phenomenon usually occurs as a secondary consequence of severe chronic inflammatory processes, major vascular disorders (ischemia), or necrotizing infections that destroy the connective supporting stroma of the glandular organ.
• Adenomatosis — A pathological condition characterized by the simultaneous development, excessive proliferation, or appearance of a large number of adenomas (benign tumors of an epithelial-glandular nature) within an organ or secretory tissue. This structural condition alters the normal histological architecture of the affected organ and can evolve, under certain clinical or genetic contexts, toward a malignant transformation (adenocarcinoma).
• Adenomectomy — A surgical intervention consisting of the complete extirpation or resection of an adenoma from an organ (most frequently applied in urology for removing a prostate adenoma or in endocrinology for pituitary or thyroid adenomas). This structural procedure aims to eliminate the compression exerted on surrounding tissues and restore the normal physiological functions of the affected system.
• Adenomegaly — An hypertrophic enlargement of the volume of a gland or a lymph node, occurring as a reaction to an inflammatory, infectious, immune, or neoplastic process in the body. This structural phenomenon manifests clinically through palpable swellings in regions such as cervical, axillary, or inguinal, requiring imaging and histopathological investigations to determine the underlying cause.
• Adenomyoma — A benign tumor formation with a mixed structure, composed of epithelial glandular elements and smooth muscle tissue. This structural benign neoplasm is most frequently encountered in the uterus, where it is considered a localized form of adenomyosis, or in the gastrointestinal tract, manifesting through pelvic pain, abnormal bleeding, or compressive symptoms.